Lutroo Imaging Launches First-in-Human Study of Radiocaine™, a Potential Breakthrough in Pain Imaging
Lutroo Imaging has officially launched a Phase 1 clinical trial of Radiocaine™, a first-of-its-kind PET radiotracer designed to make pain…
chronic pain
Chronic Pain: The Most Common and Most Ignored Public Health Crisis in America
Chronic pain affects more Americans than heart disease, cancer, and diabetes combined—yet it remains dramatically underfunded, underrecognized, and stigmatized. Discover…
Innovating Pain Management: How Journavx and Radiocaine Are Shaping a Non-Opioid Future
The opioid crisis has compelled stakeholders in the healthcare industry to seek safer alternatives for pain management. Two examples are…
Chronic Pain: Breaking the Cycle of Suffering
By addressing the physical, emotional, and economic impacts of chronic pain, we can improve lives and reduce the burden on…
Chronic pain: The $1 Trillion Dollar Problem
The economic burden of chronic pain has surpassed $1 trillion annually in the United States, driven by increasing healthcare costs…